Breaking News, Collaborations & Alliances

Theragent Enters Stem Cell Bank Production Contract with Accelerated Biosciences

The CDMO will produce cGMP-grade master cell bank for Accelerated’s human Trophoblast Stem Cells.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Theragent, a cell therapy contract development and manufacturing organization (CDMO) focused on advancing next-generation cancer and rare disease treatments, has formed an agreement with Accelerated Biosciences, a regenerative medicine innovator, to produce the cGMP-grade master cell bank (MCB) for Accelerated Biosciences’ novel human Trophoblast Stem Cells (hTSCs). Accelerated Biosciences’ hTSCs are pluripotent and immune-privileged stem cells that are derived from an ethical sou...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters